Restricting age for RV administration limits immunization rates, with delayed DTaP initiation linked to higher non-initiation.

Writing style can explain about half of observed disparities in care team response to messages sent by patients.

Preinfection COVID-19 vaccination lowers the risk for persistent post-COVID-19 conditions in children and adolescents.

FDA expands Tivicay PD (dolutegravir) approval for HIV-1 treatment to neonates from birth up to 4 weeks of age weighing at least 2kg.

Prolonged bacteremia in pediatric AHOAI increases early complications but does not dictate long-term orthopedic outcomes.

Approximately half of high-risk patients with influenza receive outpatient antiviral therapy, irrespective of insurance type.

Pediatric MRSA hospitalizations declined between 2016 and 2024, but ICU admission rates remained stable alongside shifts in drug selection.

Early-life immune activation from bacterial or viral infections may increase the risk for psychiatric disorders in childhood and adolescence.

Normalizing BMI is associated with a reduced risk for progression to stage 3 type 1 diabetes, with the association mainly observed in youth.

Older adults hospitalized for COVID-19 during the Omicron era face a higher risk for MACE and mortality than those hospitalized for influenza.

Anti-inflammatory and antihistamine therapies offer short-term fatigue relief in long COVID, but long-term benefit is unlikely.

HPV self-collection testing can expand cervical cancer screening access among patients in the setting of an opioid treatment program.